oxandrolone has been researched along with atovaquone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nightingale, SL | 1 |
1 review(s) available for oxandrolone and atovaquone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for oxandrolone and atovaquone
| Article | Year |
|---|---|
From the Food and Drug Administration.
Topics: Adrenal Cortex Hormones; Antifungal Agents; Atovaquone; Chickenpox; Child; Contraindications; Drug Labeling; Drugs, Investigational; Humans; Male; Naphthoquinones; Nonprescription Drugs; Oxandrolone; Tacrine; United States; United States Food and Drug Administration; Weight Loss | 1992 |